STOCK TITAN

Sight Sciences insider files Form 4 for minor tax-related sale

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4

Rhea-AI Filing Summary

On 07/02/2025, Sight Sciences (SGHT) Chief Commercial Officer Matthew Link filed a Form 4 reporting the sale of 4,889 common shares at an average price of $4.098 per share.

The filing notes the shares were sold solely to satisfy the executive’s tax liability related to the vesting of restricted stock units. Following the transaction, Link continues to hold 832,293 shares of SGHT, retaining more than 99% of his previous direct ownership. No derivative securities were acquired or disposed of.

The sale represents a routine, low-volume insider disposition—approximately 0.6% of the executive’s holdings—and is unlikely to materially affect investor sentiment or the company’s share-price outlook.

Positive

  • Executive retains 832,293 shares, maintaining substantial alignment with shareholders.

Negative

  • Insider sale reported, though small in size and tax-related.

Insights

TL;DR: Tax-related sale of 4,889 shares is immaterial; ownership largely unchanged—neutral signal.

The Form 4 discloses a small disposition by CCO Matthew Link at $4.098 per share to cover withholding taxes on vested RSUs. The amount sold equals roughly 0.6% of his 837k-share stake, leaving him with 832,293 shares. With no derivative activity and an explicit tax-settlement explanation, the transaction appears administrative rather than indicative of negative insider sentiment. Consequently, the event should have minimal market impact and does not alter the investment thesis for SGHT.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Link Matthew

(Last) (First) (Middle)
C/O SIGHT SCIENCES, INC.
4040 CAMPBELL AVE., SUITE 100

(Street)
MENLO PARK CA 94025

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Sight Sciences, Inc. [ SGHT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Commercial Officer
3. Date of Earliest Transaction (Month/Day/Year)
07/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/02/2025 S 4,889(1) D $4.098 832,293 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Reflects shares of the Issuer's common stock, par value $0.001 per share, sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units.
/s/ Jeremy Hayden, Attorney-in-Fact for Matthew Link 07/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many SGHT shares did Matthew Link sell on 07/02/2025?

He sold 4,889 common shares.

What was the sale price of the SGHT shares in the Form 4?

The shares were sold at an average price of $4.098 each.

Why did the Chief Commercial Officer sell SGHT shares?

The filing states the sale was to cover tax liabilities from vested restricted stock units.

How many SGHT shares does Matthew Link own after the sale?

He directly owns 832,293 shares following the transaction.

Does the Form 4 report any derivative security transactions?

No, no derivative securities were acquired or disposed of.

What percentage of his holdings did the CCO sell?

The 4,889 shares represent approximately 0.6% of his direct ownership.
Sight Sciences, Inc.

NASDAQ:SGHT

SGHT Rankings

SGHT Latest News

SGHT Latest SEC Filings

SGHT Stock Data

446.24M
41.81M
20.66%
50.37%
1.99%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MENLO PARK